Akero Therapeutics
AKRO
AKRO
173 hedge funds and large institutions have $1.85B invested in Akero Therapeutics in 2024 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 74 increasing their positions, 45 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
10% more funds holding
Funds holding: 157 → 173 (+16)
1.84% less ownership
Funds ownership: 107.88% → 106.04% (-1.8%)
24% less call options, than puts
Call options by funds: $15.3M | Put options by funds: $20M
Holders
173
Holding in Top 10
4
Calls
$15.3M
Puts
$20M
Top Buyers
| 1 | +$87.1M | |
| 2 | +$58.9M | |
| 3 | +$46.5M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$45.8M |
| 5 |
FAM
Fred Alger Management
New York
|
+$31.5M |
Top Sellers
| 1 | -$43.2M | |
| 2 | -$33.5M | |
| 3 | -$13.2M | |
| 4 |
YCM
Yiheng Capital Management
San Francisco,
California
|
-$12.4M |
| 5 |
Alkeon Capital Management
New York
|
-$11M |